High dose pancreatic enzymes in cystic fibrosis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2334211.
- Also identified by PMC identifier 1792276.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Seven patients with cystic fibrosis taking high doses of pancreatin supplements were assessed to determine whether this dose was necessary to achieve adequate fat absorption. Patients reduced their intake from a group mean of 45 to 21 capsules a day. Five patients did not have any significant alteration in fat malabsorption while taking the reduced enzyme dose.
Medical subject headings
- Cystic Fibrosis
- Pancreatin